{
    "clinical_study": {
        "@rank": "44", 
        "brief_summary": {
            "textblock": "RATIONALE: The use of axillary drains may help to prevent complications following axillary\n      lymph node dissection.\n\n      PURPOSE: This randomized clinical trial is comparing three methods of axillary drainage to\n      see how well they work following lymph node dissection in women with stage I or stage II\n      breast cancer."
        }, 
        "brief_title": "Axillary Drainage Following Lymph Node Dissection in Women With Stage I or Stage II Breast Cancer", 
        "condition": [
            "Breast Cancer", 
            "Lymphedema", 
            "Perioperative/Postoperative Complications"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Breast Neoplasms", 
                "Lymphedema", 
                "Postoperative Complications"
            ]
        }, 
        "detailed_description": {
            "textblock": "OBJECTIVES:\n\n        -  Compare high vacuum drainage vs low vacuum drainage vs simple tube drainage in patients\n           undergoing axillary surgery for stage I or II breast cancer.\n\n      OUTLINE: This is a randomized study.\n\n      Patients undergo axillary dissection, then are randomized to one of three axillary drainage\n      systems.\n\n        -  Arm I: Patients receive high vacuum drainage.\n\n        -  Arm II: Patients receive low vacuum drainage.\n\n        -  Arm III: Patients receive simple tube drainage (no vacuum). All drains are removed when\n           daily volumes are below 30 mL or at 5 days after surgery, regardless of drain volume.\n\n      Patients are followed at day 10 and at 3 months.\n\n      PROJECTED ACCRUAL: A total of 200 patients will be accrued for this study."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "DISEASE CHARACTERISTICS:\n\n          -  Diagnosis of resectable stage I or II breast cancer\n\n          -  Planned primary surgery of level II or III axillary dissection in association with\n             one of the following:\n\n               -  Wide local excision (may be done through separate incision)\n\n               -  No breast surgery\n\n               -  Bilateral surgery allowed\n\n          -  No prior mastectomy\n\n          -  No immediate breast reconstruction using implants, latissimus dorsi, or rectus\n             abdominus myocutaneous flaps at primary operation\n\n          -  Hormone receptor status:\n\n               -  Not specified\n\n        PATIENT CHARACTERISTICS:\n\n        Age:\n\n          -  18 and over\n\n        Sex:\n\n          -  Female\n\n        Menopausal status:\n\n          -  Not specified\n\n        Performance status:\n\n          -  Not specified\n\n        Life expectancy:\n\n          -  Not specified\n\n        Hematopoietic:\n\n          -  Not specified\n\n        Hepatic:\n\n          -  Not specified\n\n        Renal:\n\n          -  Not specified\n\n        Other:\n\n          -  Not pregnant\n\n        PRIOR CONCURRENT THERAPY:\n\n        Biologic therapy:\n\n          -  Not specified\n\n        Chemotherapy:\n\n          -  Not specified\n\n        Endocrine therapy:\n\n          -  Not specified\n\n        Radiotherapy:\n\n          -  No prior radiotherapy\n\n        Surgery:\n\n          -  See Disease Characteristics\n\n          -  No prior axillary surgery"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "firstreceived_date": "May 2, 2000", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT00005600", 
            "org_study_id": "CDR0000067713", 
            "secondary_id": [
                "RMNHS-1489", 
                "EU-20004"
            ]
        }, 
        "intervention": {
            "intervention_name": "management of therapy complications", 
            "intervention_type": "Procedure"
        }, 
        "keyword": [
            "stage I breast cancer", 
            "stage II breast cancer", 
            "lymphedema", 
            "perioperative/postoperative complications"
        ], 
        "lastchanged_date": "November 5, 2013", 
        "link": {
            "description": "Clinical trial summary from the National Cancer Institute's PDQ\u00ae database", 
            "url": "http://cancer.gov/clinicaltrials/RMNHS-1489"
        }, 
        "location": [
            {
                "facility": {
                    "address": {
                        "city": "London", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "SW3 6JJ"
                    }, 
                    "name": "Royal Marsden NHS Foundation Trust - London"
                }
            }, 
            {
                "facility": {
                    "address": {
                        "city": "Sutton", 
                        "country": "United Kingdom", 
                        "state": "England", 
                        "zip": "SM2 5PT"
                    }, 
                    "name": "Royal Marsden NHS Foundation Trust - Surrey"
                }
            }
        ], 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "official_title": "Optimum Drainage of the Axilla After Lymph Node Dissection: A Randomized Prospective Study", 
        "overall_official": {
            "affiliation": "Royal Marsden NHS Foundation Trust", 
            "last_name": "Gerald Gui, MD, MS, FRCS(Edin), FRCS(Eng)", 
            "role": "Study Chair"
        }, 
        "overall_status": "Active, not recruiting", 
        "oversight_info": {
            "authority": "United States: Federal Government"
        }, 
        "phase": "N/A", 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT00005600"
        }, 
        "source": "National Cancer Institute (NCI)", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Royal Marsden NHS Foundation Trust", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 1997", 
        "study_design": "Allocation: Randomized, Primary Purpose: Supportive Care", 
        "study_type": "Interventional", 
        "verification_date": "December 2005"
    }, 
    "geocoordinates": {
        "Royal Marsden NHS Foundation Trust - London": "51.508 -0.128", 
        "Royal Marsden NHS Foundation Trust - Surrey": "51.361 -0.194"
    }
}